Kronos Bio

KRON

KRON Kronos Bio NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    KRON Chart
    See on advanced chart >

    About

    Kronos Bio, Inc. was incorporated under the laws of the State of Delaware on June 2, 2017. The company is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes...
    • Highlight
      A company that develops therapeutics for cancer by targeting dysregulated transcription
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/09/2020
    • Established Date
      06/02/2017
    • Full-time Employees
      62
    • Address
      1300 So. El Camino Real Suite 300 San Mateo California 94402
    • Tel
      1-650-7815200
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock